These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6212749)

  • 41. [Neocarzinostatin therapy of advanced renal cell carcinoma].
    Tari K; Satake I; Kojima S; Tsujii T; Yonese J
    Gan To Kagaku Ryoho; 1988 Sep; 15(9):2719-23. PubMed ID: 2970825
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A model for the activation and inactivation of neocarzinostatin, an antitumor protein.
    Lewis RS; Jung G; Köhnlein W
    Biochim Biophys Acta; 1980 Jun; 608(1):138-46. PubMed ID: 6446321
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reinforcing radiotherapy of gallbladder cancer with aclarubicin and neocarzinostatin.
    Okuyama S; Mishina H; Funaki K; Mori T
    Tohoku J Exp Med; 1990 Jun; 161(2):155-6. PubMed ID: 2148231
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Deoxyribonucleic acid sugar damage in the action of neocarzinostatin.
    Hatayama T; Goldberg IH
    Biochemistry; 1980 Dec; 19(25):5890-8. PubMed ID: 6450615
    [No Abstract]   [Full Text] [Related]  

  • 45. [Studies on the stability of antitumor protein, neocarzinostatin. I. Stability of solution of neocarzinostatin (author's transl)].
    Kono M; Haneda I; Koyama Y; Kikuchi M
    Jpn J Antibiot; 1974 Dec; 27(6):707-14. PubMed ID: 4282494
    [No Abstract]   [Full Text] [Related]  

  • 46. [Treatment of meningeal carcinomatosis--neocarzinostatin perfusion therapy in the CSF pathway].
    Uemura S; Matsukado Y; Fujioka S; Kuratsu J; Sonoda H; Yano T; Ohtsuka T; Yoshioka S
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1794-800. PubMed ID: 2931051
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neocarzinostatin: carboxyl-terminal-43-peptide residue of apo-neocarzinostatin as the binding site of neocarzinostatin-chromophore.
    Edo K; Saito K; Akiyama Y; Mizugaki M; Koide Y; Ishida N
    Chem Pharm Bull (Tokyo); 1986 Dec; 34(12):5180-3. PubMed ID: 2952300
    [No Abstract]   [Full Text] [Related]  

  • 48. In vitro release of thymine from DNA by neocarzinostatin.
    Ishida R; Takahashi T
    Biochem Biophys Res Commun; 1976 Jan; 68(1):256-61. PubMed ID: 2169
    [No Abstract]   [Full Text] [Related]  

  • 49. Mechanism of the effect of organic solvents and other protein denaturants of neocarzinostatin activity.
    Kappen LS; Goldberg IH
    Biochemistry; 1979 Dec; 18(25):5647-53. PubMed ID: 160246
    [No Abstract]   [Full Text] [Related]  

  • 50. The generalization of pre-neocarzinostatin and antagonism of neocarzinostatin-induced DNA scission in vitro.
    Jung G; Lewis RS; Köhnlein W
    Biochim Biophys Acta; 1980 Jun; 608(1):147-53. PubMed ID: 6446322
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A facile method of purification of neocarzinostatin, an antitumor protein.
    Samy TS; Hu JM; Meienhofer J; Lazarus H; Johnson RK
    J Natl Cancer Inst; 1977 Jun; 58(6):1765-8. PubMed ID: 140942
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Diagnosis and targeting therapy of colorectal cancer using antibody].
    Yamaguchi T; Takahashi T; Kitamura K; Otsuji E; Kotani T; Kato M; Yata Y; Okamoto K; Nishi H; Ichikawa D; Yamamoto K
    Gan To Kagaku Ryoho; 1996 Apr; 23(5):549-53. PubMed ID: 8678511
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neocarzinostatin versus m-AMSA or doxorubicin in hepatocellular carcinoma.
    Falkson G; MacIntyre JM; Schutt AJ; Coetzer B; Johnson LA; Simson IW; Douglass HO
    J Clin Oncol; 1984 Jun; 2(6):581-4. PubMed ID: 6327926
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phase I study of neocarzinostatin in children with cancer.
    Rivera G; Howarth C; Aur RJ; Pratt CB
    Cancer Treat Rep; 1978 Dec; 62(12):2105-7. PubMed ID: 156067
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An uptake of fluorescein isothiocyanate labeled neocarzinostatin into the cancer and normal cells.
    Sakamoto S; Maeda H; Ogata J
    Experientia; 1979 Sep; 35(9):1233-5. PubMed ID: 158538
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Zinostatin and doxorubicin. A combination phase I study.
    Issell BF; Ginsberg SJ; Comis RL
    Cancer Clin Trials; 1981; 4(3):323-6. PubMed ID: 6269771
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Local chemotherapy of malignant glioma. Intra-tumoral administration of neocarzinostatin].
    Uemura S; Matsukado Y; Kuratsu J; Sonoda H; Ohtsuka T; Yoshioka S; Yamada M
    Neurol Med Chir (Tokyo); 1986 Jun; 26(6):468-74. PubMed ID: 2430207
    [No Abstract]   [Full Text] [Related]  

  • 58. Studies on surgical adjuvant chemotherapy for colorectal cancer and administration of neocarzinostatin into the lumen of the colon or rectum using a double balloon catheter and iontophoresis.
    Akao S
    Nihon Geka Hokan; 1981 Jan; 50(1):67-82. PubMed ID: 6456709
    [No Abstract]   [Full Text] [Related]  

  • 59. Cytotoxic and mutagenic effects of neocarzinostatin in wild-type and repair-deficient yeasts.
    Mousstacchi E; Favaudon V
    Mutat Res; 1982 Apr; 104(1-3):87-94. PubMed ID: 6210843
    [No Abstract]   [Full Text] [Related]  

  • 60. Neocarzinostatin: an antitumor protein a preliminary x-ray diffraction study.
    Sieker LC; Jensen LH; Samy TS
    Biochem Biophys Res Commun; 1976 Jan; 68(2):358-62. PubMed ID: 130133
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.